The following manuscripts were published by THECA partners.
Haselbeck A, Tadesse B, Park J, Marks F, et al. Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics. Vaccines 2021; 9(3), 281
TyVAC supplement: Typhoid fever and the introduction of the typhoid conjugate vaccine in Africa and Asia, 15 Mar 2019
Andrews JR, Baker S, Marks F, et al. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Lancet Infect Dis 2019; 19(1): e26-e3
Bilcke J, Antillon M, Pieters Z, et al. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study. Lancet Infect Dis 2019; 19(7): 728-39